Embed Size (px)
Citation preview
Its not about Mini MBAs or
business planbusiness plan competitions!p
Alan Scrase,Alan Scrase,and
Dr Simon Brown
Today’s AgendaToday’s Agenda
• The guiding principles and thoughts we use to design and deliver PhD and post doc
i li icommercialisation programmes.
• How to get engagement and enthusiasm to deliver tangible and intangible results that last.
I t d tiIntroductions
• Alan Scrase• Programme co‐creator and Commercial LeadProgramme co creator and Commercial Lead
• Dr Simon Brown• Programme co creator and Education Lead• Programme co‐creator and Education Lead
• Complementary skills but common agenda Making• Complementary skills but common agenda – Making it easier and more rewarding for researcher’s to achieve Impact via intensive trainingachieve Impact via intensive training
It’ ll b t IMPACTIt’s all about IMPACT• https://www timeshighereducation com/features/bruising‐effect‐impact‐agendahttps://www.timeshighereducation.com/features/bruising effect impact agenda
• “… in today’s “publish or perish” culture, academics are expected to write more, get more grants,are expected to write more, get more grants, engage more – and are judged against these outputs. This has made the … community very uneasy, …”
Lik i h iLike it or hate it.. “Impact” is here to staypact s e e to stay
D l i E i d E i l• Developing Enterprise and Entrepreneurial Competencies can help all academics identify the impact their work has and allow them to surviveimpact their work has and allow them to survive and grow in the years ahead.
UnderlyingUnderlying Premise
Post Graduates and Post‐Doctoral researchers are:
a rich untapped seam of IP and opportunities
the Cinderella group when it comes to enterprise and entrepreneurship education
PhD and Post Doc training Genesistraining Genesis
• Created and delivered SETsquared qfunded Researcher to Innovator (R2I) programme (2012)
i d h l h i di id l• Designed R2I to help the individualPhD
• SETsquared and Innovate UK• SETsquared and Innovate UK identified need to support academic research teams to overcome the valley of death (20%overcome the valley of death (20% of SETsquared incubator co’s came from Academia)
• Teams require minimum ofECR, PI, TTOandand ideally Business Mentor
You have to engageYou have to engage the PhDs.
• How have the PhDs got to where they are?• What skills and competencies do they already p y yhave?
• Do these prepare them for their careers?p p
• What careers do they expect?• What careers do they expect?
Some “Motivation”
95% of 25K (UKRI figure)
Researcher toResearcher to Innovator
• For PhDs• will enable the brightest and best academic• ..will enable the brightest and best academic researchers from across the SETsquared Partnership universities and any academicPartnership universities and any academic discipline to transform themselves into successfulinnovators.
• Participants will leave the programme capable of realising and potentially commercialising their ideasg p y g
• expertise in the wider world and engage with industry. dust y.
Wh t did l ?What did we learn?
• Acknowledge that these people have avoided doing things that they think will take them away from g y ytheir life goal, to focus on their passion ‐ discipline.
• They are brilliant at avoiding things they find risky.They are brilliant at avoiding things they find risky.• They need to be helped to step away from the safesafe…
• Bandura – Self Efficacy.
Anna Kirketerp’smodel
aim to develop the PINK zonep
SSuccesses
• SETsquared ‐ http://www.setsquared.co.uk/• ICURe• ICURe ‐https://innovateuk.blog.gov.uk/2018/04/11/innovation‐to‐commercialisation‐of‐university‐research‐tion to commercialisation of university researchicure/
• Action for Impact ‐Action for Impact https://microsites.ncl.ac.uk/nubsstaffblog/2018/06/01/action‐for‐impact‐training‐opportunity// / p g pp y/
How to engageHow to engage them?
• PhDs when you can get to them – can see the benefits.
• How do you get to the PhDs?
• Through their PIs.• PIs – don’t typically have these skills – and it hasn’tstopped them…
You have to convince the PI that they will benefitthey will benefit.
• R2I and subsequent programmes like ICURe all have q p gto sell the benefits of their PhD or Post Doc’s training – to the PIs – not the PhD/Post Docs.
• Evidence from R2I and ICURe shows;• Highly skilled researchers who can communicate with industry become advocates for their research.
• Open up new opportunities for their research.C k f ll b i• Create new networks for collaboration /commercialisation
More skilledMore skilled Academics …
• Better Research applications – with evidence of commercial need.
• Better publications – with industrial collaboration• Better security with broader funding for team• Better security – with broader funding for team• Better impact case studies – with evidence of
li ti f th happlication of the research
F lFor example
• Shelby Temple – R2I and ICUReand ICURe
• Azul Optics• https://azuloptics.com/bbsrc_ioy2017/
or
• Shakardokht Jafari – R2I and ICURe
• Trueinvivo Ltd• https://www linkedin c• https://www.linkedin.com/in/shakardokht‐jafari‐44554442/jafari 44554442/
L l tLessons learntDeveloping the Entrepreneurial competencies of the academics benefits everybody;
h h h k l f h1. The PhDs – they can take control of their careers.2. The PIs – they get better researchers, better
h b tt t k b tt bli tiresearch, better networks, better publications, better funding, better careers.
3 TTOs they can better share the workload and3. TTOs – they can better share the workload and responsibility, better commercialisationoutcomes
4. The Institution – they can demonstrate genuine Impact.
ICURe ModelICURe Model
h hRecruitment Take to Market
Private funding
Licensing
Further Research
InnovateU
funding
Numerous sources
including
InnovateUK Aid for Start-Ups funding
PIs and ECRs return with business including
HEIs, TTO teams
Sponsored research
business knowledge, skills and contacts to HEI sector 3 h k3 4 Day Optionso
n le
ns
sector 3 month Work programme
3-4 Day Residential
HEFCE + InnovateUK
Options
roundabout
Sele
ctio
InnovateUKfunding
IPSOS MORIICUR i ff ti d i l i t t f
IPSOS MORI• ICURe is an effective and an economical instrument for
accelerating the commercialisation of academic research
and producing a range of wider benefits
• there was a high rate additionality associated with its• there was a high rate additionality associated with its
results (81 percent), and its benefits exceeded its costs.
IPOS Headline IImpacts
• Participation in the programme increased and deepened links
between participating academics and industry accelerating thebetween participating academics and industry, accelerating the
commercialisation and the technology development process.
• The ICURe programme is estimated to have created £3.94 of
economic benefit for every £1 investedeconomic benefit for every £1 invested.
• https://www.gov.uk/government/publications/icure‐
evaluation‐of‐pilot‐programme
INNOVATION TO COMMERCIALISATION OF UNIVERSITY RESEARCH
Th ICUR ff i i h i h i ll
28%of Entrepreneurial Leads are female
226teams successfully
TheICURe programme offers universityresearcherswithcommercially‐promisingideas the ability to ‘getoutof the lab’andvalidatetheir ideas in
themarketplace.
Leads are female completed
62450+499
newcompanies created
20,000+business contacts made
450+Jobs created
applications
Total additional investment
784 participants• Entrepreneurial Leads
• Public research• Private research• Licensing • P i t i t t
£100+ MEntrepreneurial Leads
• Senior Researchers• Business Advisors• Tech Transfer Officers
• Private investment• ICURe follow‐on funding
IPOS Impacts
ICUR ill h i i ff h i i h l d
IPOS Impacts
• ICURe still has a positive effect when participants have completed complementary programmes, though this effect is smaller than for h h h b k d ( h b d)those without this background (as might be expected).
• Evidence from the case studies suggested that participation in R2I provided ECRs with experience in contacting prospective customers about a technology and encouraged ECRs to be in regular contact with their TTO representative.
• These precursory activities gave participants a basic understandingThese precursory activities gave participants a basic understanding of commercialisation activity which made assimilation during the programme more efficientprogramme more efficient.
IPOS Impacts
• Participation in ICURe complemented by the Researcher to Innovator
IPOS Impacts
• Participation in ICURe complemented by the Researcher to Innovator
programme.
• Where participating teams had ECRs that participated in the R2I
programme, the likelihood of commercialisation rose to 54%
(relative to 39% if the ECR had not participated in R2I).
Th R2I it lf l d t h i fl d th• The R2I programme itself also appeared to have influenced the
likelihood non‐participating teams achieving a commercialisation
result
(40% for non‐participating teams that took part in R2I relative to 6%
of non‐participants that did not).
G i f dGoing forward
• Creating suites of programmes that are stand alone or feed into ICURe.
• Delivering “one day” intensiveDelivering one day intensive action learning about principles and practice of customer discovery and validation
• Running mini ICURe programmes g p gwith smaller budgets for very targeted teams
Evaluation modelsEvaluation models developed
• Existing models of entrepreneurial intent (Ajzen et al 2009; Linan et l 2011)al 2011)
• Used in Universities and other contexts (Newbery et alcontexts (Newbery et al 2015; Newbery 2015)
• We started with Entrepreneurial pIntent and developed a new Commericialising Intent measure
Key Metrics
Feedback So FarFeedback So Far“I thought I knew who would use and pay for our technology.I thought I knew who would use and pay for our technology.But real feedback from the market dramatically changed our
approach to commercialisation”
“gave us a powerfulgave us a powerful toolkit to test our
ideas in the k l d
“Now I see things from the market point of view rather than the
research point of view”marketplace and make them attractive to customers and
research point of view”
“put us in contact with dozens of customers, licensing partners and investors We have the confidence to take our investors” partners and investors. We have the confidence to take our
optoelectronic devices to market”
“Engaging with customers, we uncovered big Engaging with customers, we uncovered big markets for our antimicrobial technology. We’ve created a new company to exploit the exciting
opportunities!”pp
